Which dyskinesia scale best detects treatment response?-Reference-Cited by-同舟云学术

Which dyskinesia scale best detects treatment response?

Published:2013-02-06 Issue:3 Volume:28 Page:341-346
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Goetz Christopher G.¹,Stebbins Glenn T.¹,Chung Kathryn A.²,Hauser Robert A.³,Miyasaki Janis M.⁴,Nicholas Anthony P.⁵,Poewe Werner⁶,Seppi Klaus⁶,Rascol Olivier⁷,Stacy Mark A.⁸,Nutt John G.²,Tanner Caroline M.⁹,Urkowitz Alison¹⁰,Jaglin Jean A.¹,Ge Song¹

Affiliation:

1. Department of Neurological Sciences; Rush University Medical Center; Chicago; Illinois; USA

2. Department of Neurology; Oregon Health Sciences University and Portland VA Medical Center; Portland; Oregon; USA

3. Department of Neurology; University of South Florida; Tampa; Florida; USA

4. The Edmond J. Safra Program in Parkinson's Disease; University of Toronto; Toronto; Ontario; Canada

5. Department of Neurology; University of Alabama and Birmingham VA Medical Center; Birmingham; Alabama; USA

6. Department of Neurology; Innsbruck Medical University; Innsbruck; Austria

7. Clinical Investigation Center CIC9302 and Departments of Clinical Pharmacology and Neuroscience, INSERM; University Hospital of Toulouse and University of Toulouse III; Toulouse; France

8. Department of Neurology; Duke University; Durham; North Carolina; USA

9. Parkinson's Institute and Clinical Center; Sunnyvale; California; USA

10. Michael J. Fox Foundation for Parkinson's Research; New York City; New York; USA

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference26 articles.

1. Levodopa-induced dyskinesias;Fabbrini;Mov Disord.,2007

2. Motor fluctuations and dyskinesias in Parkinson's disease;Nutt;Parkinsonism Relat Disord.,2001

3. Drug insight: new drugs in development for Parkinson's disease;Colosimo;Nat Clin Pract Neurol.,2006

4. Pathophysiology of levodopa-induced dyskinesia: potential or new therapies;Bézard;Nat Rev Neurosci,2001

5. Idazoxan, an alpha-2 antagonist, and L-DOPA-induced dyskinesias in patients with Parkinson's disease;Rascol;Mov Disord.,2001

Cited by 71 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A computerized assessment tool for the upper extremities motor performance in individuals with Parkinson's disease;Biomedical Signal Processing and Control;2024-01

2. Levodopa Carbidopa Intestinal Gel in Advanced Parkinson’s Disease: DUOGLOBE Final 3-Year Results;Journal of Parkinson's Disease;2023-07-25

3. A single centre prospective study of three device-assisted therapies for Parkinson’s disease;npj Parkinson's Disease;2023-06-29

4. Doxycycline to treat levodopa-induced dyskinesias in Parkinson's disease: a preliminary study;Arquivos de Neuro-Psiquiatria;2023-05

5. 5-HT_1A agonists for levodopa-induced dyskinesia in Parkinson's disease;Neurodegenerative Disease Management;2023-04